Australian Medical Association Pushes Legislation Against E-cigarette Behavior

Regulations by 2FIRSTS.ai
May.27.2024
Australian Medical Association Pushes Legislation Against E-cigarette Behavior
Australia Medical Association pushes for legislation to combat e-cigarette use, facing opposition within government parties. Vote to take place in June.

According to The Guardian on May 26th, the Australian Medical Association is pushing for parliament in Canberra to pass legislation to combat e-cigarette use. The bill is expected to be voted on in June. The ban proposed by the Australian Labor Party on the import and commercial ownership of e-cigarettes is facing obstacles.

 

According to reports, the Australian National Party is hoping to legislate similar restrictions on e-cigarette behavior as tobacco, without the need for a prescription, while also enforcing the same regulations on packaging and taxes. The Australian Liberal Party sometimes allows its smaller coalition partners to dictate the course, and Peter Dutton has expressed dissatisfaction with the ban. However, the party's Minister for Market Education, Sarah Henderson, and others have publicly criticized e-cigarette behavior, describing it as a "menace" in schools.

 

Overall, crossing party lines and working with the Greens is often the safest route in the Senate. In May of this year, the Greens' health spokesperson Jordon Steele-John agreed with a recent survey report that the bill should be passed. However, he cautioned in other comments that the Greens do not "support banning e-cigarettes for adults."

 

This may include revising laws to ensure that individuals are not criminalized for possession, providing adequate support for smoking cessation, and restricting advertising of e-cigarettes to doctors. The party will decide on its stance in the next two weeks.

 

According to reports, the President of the Australian Medical Association, Steve Robson, has given a direct message to lawmakers who "seem more willing to listen to tobacco lobbying groups and political donors than to parents, health departments, and children." He stated, "We hope to encourage the opposition party and others to do the right thing, not listen to donors, and protect Australia's children from the dangers of e-cigarettes.

 

He expressed being "shocked" and "disappointed" to reporters in Canberra, as the National Party is seeking to tax e-cigarettes instead of banning non-prescription e-cigarettes. He also posed serious questions to the Greens party.

 

He believes, "The Green Party is a political party that places the future of the next generation at the core of its policies, which is obviously something they should support, if they truly prioritize the health and well-being of children.

 

Robson asked Health Minister Mark Butler if the regulation of e-cigarettes is stricter than tobacco, despite the latter being more harmful. In order to prevent this situation, is it possible that restrictions on tobacco based on birth year, similar to what New Zealand has attempted, may be implemented.

 

Butler said at the National Press Club conference in May 2023 that the difference is that "tobacco has been with us for too long," while e-cigarettes are still "relatively new." He said, "If we knew then what we know now about the introduction of tobacco, I hope the government would have taken immediate action, just as I now want to tackle e-cigarettes. We have an opportunity now, with e-cigarettes becoming so widespread, accepted, and normalized...to seize this moment before taking any action becomes extremely difficult.

 

Everyone agrees that children should not use e-cigarettes, but that does not mean burdening legislation with the most stringent possible methods. If the goal is not to criminalize a particular group of individuals, then the relevant laws should be revised to ensure that this does not happen. If we had known the current situation when introducing tobacco, the government may have immediately banned tobacco, just as it is now aiming to address e-cigarettes.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

EU Commission Clarifies Vaping, Smokeless Nicotine Use in Proposed Cardiovascular Checks
EU Commission Clarifies Vaping, Smokeless Nicotine Use in Proposed Cardiovascular Checks
The European Commission has clarified to 2Firsts that its proposed cardiovascular health checks would assess smoking, vaping and the use of smokeless nicotine products as part of patients’ medical histories. The Commission also said Member States may organise additional checks within their healthcare systems. In the same response, it pointed to JRC research on e-cigarettes, heated tobacco products and nicotine pouches that has fed into the evaluation of EU tobacco legislation.
Nov.09
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
Product | OXVA Introduces XLIM PRO 4 With Liquid-Level Anti-Burn Technology and Dedicated Pods
Product | OXVA Introduces XLIM PRO 4 With Liquid-Level Anti-Burn Technology and Dedicated Pods
Vaping brand OXVA introduced the XLIM PRO 4 refillable pod system in October 2026, featuring Anti-Burn Tech (ABT) based on smart e-liquid-level detection. The system can issue refill alerts and stop power output when e-liquid levels become too low. ABT requires the XLIM PRO 4 device and a dedicated XLIM ABT cartridge. Standard XLIM pods remain compatible but do not support ABT protection. OXVA previously introduced temperature-based anti-burn technology in the XLIM Pro 2 DNA, developed with Evolv. The new device features a 1,800mAh battery, 5–30W output and a 0.98-inch HD color screen. OXVA's official store lists the device at $37.90 and dedicated ABT replacement cartridges at $12.99. Independent testing confirmed the low-liquid protection response but recorded varying cartridge lifespans.
product
Oct.30
NATO Executive Director David Spross Sees U.S. Vape Regulation Improving, Calls for More PMTA Authorizations and Warns of 2027 State Tax Pressure
NATO Executive Director David Spross Sees U.S. Vape Regulation Improving, Calls for More PMTA Authorizations and Warns of 2027 State Tax Pressure
The National Association of Tobacco Outlets is calling for more FDA marketing authorizations, greater transparency in the PMTA process and continued enforcement against unauthorized e-cigarettes, even as its executive director, David Spross, points to recent regulatory developments as signs of progress. At the state level, excise taxes, flavor restrictions and vapor product directories remain major issues for tobacco retailers. By August 2026, 17 states had enacted laws establishing state-managed e-cigarette directories or similar systems.
Innovation
Sep.29 by 2Firsts Perspectives
Russia's State Duma Passes Tobacco and Nicotine Ingredient Disclosure Bill, Targeting 2027 End to Trade-Secret Protection for Certain Harmful Ingredient Data
Russia's State Duma Passes Tobacco and Nicotine Ingredient Disclosure Bill, Targeting 2027 End to Trade-Secret Protection for Certain Harmful Ingredient Data
Russia's State Duma passed a government-sponsored amendment on November 11, 2026, by 414 votes to none, seeking to prevent businesses from classifying information on the presence and number of types of certain harmful ingredients in tobacco and nicotine-containing products as trade secrets. The measure covers ingredients capable of increasing nicotine dependence or exhibiting toxic, carcinogenic, mutagenic or reproductive toxicity, including substances that acquire such properties during heating or smoldering. Bill No. 1286415-8 would amend Article 5 of Federal Law No. 98-FZ on Commercial Secrets and is scheduled to take effect on January 1, 2027. The bill has cleared all three readings in the State Duma but has not completed the remaining legislative procedures.
Regulations
Nov.12 by 2Firsts Perspectives
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives